2种全身麻醉用于老年腹腔镜胆囊手术的比较被引量：4

在线阅读下载PDF

导出

摘要目的:比较依托咪酯与丙泊酚复合瑞芬太尼应用于老年患者静脉全身麻醉下腹腔镜胆囊切除术的麻醉效果及不良反应。方法:选择我院90例行静脉全身麻醉下腹腔镜胆囊切除术老年患者按随机数字表分为2组,Ⅰ组45例,Ⅱ组45例。Ⅰ组实施瑞芬太尼、依托咪酯全凭静脉麻醉,Ⅱ组实施瑞芬太尼、丙泊酚全凭静脉麻醉。观察2组患者术中血流动力学指标,记录苏醒时间与拔管时间,观察不良反应发生情况。结果:Ⅱ组患者麻醉诱导后(T1)SBP、DBP均较诱导前(T0)明显降低,均具有显著性差异(P<0.05),但Ⅰ组没有明显变化;Ⅱ组麻醉诱导后(T1)DBP明显高于Ⅰ组,具有显著性差异(P<0.05),Ⅰ组和Ⅱ组气管插管即刻(T2)、气管插管后3 min(T3)、腹腔镜置入即刻(T4)、腹腔镜置入3 min(T5)、气管拔管即刻(T6)、气管拔管后3 min(T7)与诱导前(T0)比较均无明显改变,Ⅰ组和Ⅱ组组间各时点亦无明显差异;Ⅰ组和Ⅱ组的苏醒时间分别为16.16±5.86 min和10.84±4.06 min,Ⅰ组和Ⅱ组的气管拔管时间分别为18.91±6.23 min和14.40±5.38 min,2组具有显著性差异。结论:施瑞芬太尼联合依托咪酯全凭静脉麻醉用于老年腹腔镜胆囊切除术具有麻醉诱导平稳、镇痛效能高、术中可控性好的优势,但瑞芬太尼联合丙泊酚全凭静脉麻醉方法的苏醒时间及拔管时间更短及不良反应发生率更低,临床应根据需要合理选择麻醉方法。

作者卢清凤梁小军刘伟明刘妮

机构地区岑溪市人民医院

出处《现代临床医学》 2014年第1期52-53,55,共3页 Journal of Modern Clinical Medicine

关键词胆囊切除术腹腔镜老年依托咪酯丙泊酚瑞芬太尼

分类号 R614.24 [医药卫生—麻醉学]

引文网络
相关文献

参考文献7

1覃鲁.硬膜外阻滞与全麻在腹腔镜胆囊切除术中的效果比较[J].国际医药卫生导报,2011,17(11):1322-1324. 被引量：3
2Kim JH,Kim JH,Han SH. Alfentanilis comparableto remifentanil in preventing withdrawal movement following rocuronium injection[J].{H}JOURNAL OF CLINICAL ANESTHESIA,2009,(01):9-12.
3Moerman AT,Herregods IL,De Vos MM. Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients[J].{H}Anesthesia and Analgesia,2009,(03):828-834.
4Turgut N,Turkmen A,Ali A. Remifentanil-propofol VS dexmedetomidine propofol-anesthesia for supratentorial craniotomy[J].Middle East J Anesthesio1,2009,(01):63-70.
5Begec Z,Demirbilek S,Ozturk E. Remifentanil and propofol for tracheal intubation without muscle relaxant in children:the effects of ketamine[J].{H}European Journal of Anaesthesiology,2009,(03):213-217.
6李军祥,宋华勇,刘娟,左云霞,王晓.依托咪酯持续输注用于全身麻醉诱导和持续输注维持的临床观察[J].华西医学,2009,24(10):2543-2546. 被引量：34
7曾因明,邓小明,刘进,黄宇光,姚尚龙,于布为,王志萍,王国林,王俊科,古妙宁,吴新民,张宏,李文志,李立环,郭曲练,熊利泽.依托咪酯临床应用指导意见[J].国际麻醉学与复苏杂志,2008,29(4):382-385. 被引量：90

二级参考文献40

1韩雪萍,周志刚,马君志.依托咪酯全凭静脉麻醉对胃癌根治术患者围手术期血清皮质醇含量的影响[J].郑州大学学报（医学版）,2006,41(2):342-344. 被引量：25
2Mille'Anesthesia. Miller Anesthesia. 6th, 2005 : 354.
3Schuttler J, Schwilden H, Stoeckel H. Infusion strategies to investigate the pharmacokinetics and pharmacodynamics of hypnotic drugs: etomidate as an example. Eur J Anaesthesiol, 1985, 2: 133-142.
4Yeung JK, Led PJ. A review of etomidate for rapid sequence intubation in the emergency department. PHARMACOTHERAPY ? CJEM, 2002, 4 : 192-198.
5Sear JW, Wahers FJ, Wilkins DG, et al. Etomidate by infusion for neuroanaesthesia. Kinetic and dynamic interactions with nitrous oxide. Anaesthesia, 1984, 39 : 12-18.
6Krakoff J, Koch CA, Calis KA, et al. Use of a parenteral propylence glycol-containing etomidate preparation for the long term management of ectopic Cushing's syndrome. J Clin Endocrinol Metab, 2001,9: 4104.
7Annane D. ICU physicians should abandon the use of etomidate. Intensive Care Med, 2005, 1 : 325-326.
8Diago MC, Amado JA, Otero M, et al. Antradrenal action of a subanaesthetic dose of etomidate. Anaesthesia, 1988, 43 : 644-645.
9Olkkola KT, Tammisto T. Quantitation of the interaction of rocuronium bromide with etomidate, fentanyl, midazolarn, propofol, thiopentone, and isoflurane using closed-loop feedback control of infusion of rocuronium. Eur J Anaesthesiol, 1994, 9 : 99-100.
10Thomas A. Crozier MD. Endocrinological changes following etomidate, midazolam, or methohexital for minor surgery. Anesthesiology, 1987, 66: 628-635.